Company intelligence / Profile preview

iCubate

Huntsville, Alabama, United Statesicubate.com ↗

Ownership: Private
Development stage: Other

Overview

iCubate has developed and commercialized rapid syndromic testing solutions for infectious diseases using its proprietary amplicon rescued multiplex PCR platform. The company offers FDA-cleared and CE-marked assays for the detection of bloodstream infections and antibiotic resistance markers. Its products enable laboratories to deliver actionable results quickly to improve patient care.

Therapeutic areas: Infectious Diseases
Modalities: DevicePCR-based diagnostic assay (Multiplex polymerase chain reaction)
Industry: Molecular Diagnostics

Partnerships

Wondfo Biotech (joint venture in China for molecular diagnostics)

Beyond the preview

Go deeper on iCubate.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on iCubate.

Explore the full profile